Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 11, 2026 · Investor press release
Summit Therapeutics Inc.
7
Investor press release
Jun 11, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Investor press release |
| Primary topic | Investor press release |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Summit Therapeutics Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. ) 601 Brickell Key Drive, Suite 1000 , Miami , FL 33131 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: (305) 203-2034 Not applicable (Former Name or Former Address, If Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obli… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 10, 2026 |
| Accession number | 0001599298-26-000052 |
| Reported items | Regulation FD disclosure (investor press release or presentation) See Analysis tab for workforce implications |
